ERBB2 and breast cancer: As the highest-grade invasive breast cancer, basal-like breast cancer (BLBC) is often incorporated into triple-negative breast cancer, which is featured as the lack of estrogen receptor, progesterone receptor, and human epidermal growth factor 2 receptor expressions, making up for approximately 15% of breast cancers (4–8).